| Resources |
|
| Government |
| Quick access to information based on government's structure
|
|
 |
|
|
Limited Coverage Drugs - Special Authority Criteria
| Generic Name / Strength / Form |
| codeine sustained release |
| Criteria |
Approval Period |
1. Diagnosis of cancer
PLUS
patients who are unable to tolerate or receive an adequate response to the regular dosage forms of codeine. |
1. First approval: One year
Renewals: One year
|
| OR |
2. Pain management in a specified chronic pain diagnosis*
PLUS
patients who are unable to tolerate or receive an adequate response to the regular dosage forms of codeine. |
2. First approval: One year
Renewals: One year |
Practitioner Exemptions
- No practitioner exemptions
Special Notes
- *Details regarding patient's condition and previous medication history are required.
- Renewal requests should provide update on patient’s current dose and condition.
- Codeine SR is a full benefit for patients registered with the Palliative program.
Online Forms (PDF)
Click on the link to complete a special authority request form.
|
|
|